News — BRONX, NY—DECEMBER 15, 2022—Cardiology researchers at and have received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to explore the underlying causes of heart failure among Hispanics/Latinos, who are at heightened risk for heart disease. Investigators will take a novel approach to assess risk: by simultaneously evaluating heart function and the relationship between the heart and the aorta, the large artery that conveys oxygen-rich blood from the heart’s left ventricle to the rest of the body.
Importance of Diversity in Clinical Research
“Hispanics make up 20% of the U.S. population and, as we found in our earlier research, they have a higher risk of heart failure compared to whites and are underrepresented in cardiac clinical trials,” said , principal investigator on the grant, professor of medicine and of epidemiology & population heath at Einstein and director of clinical cardiology research and of cardiovascular epidemiology at Einstein and Montefiore. “This funding will help us better understand and predict heart failure among Hispanics—and potentially other population groups.”
According to the U.S. Centers for Disease Control and Prevention, heart disease was the leading cause of death in in 2018 and the second-leading cause of death in . Compared with non-Hispanic whites, Hispanics/Latinos have a higher incidence of heart failure, tend to develop heart failure earlier, and tend to have more comorbidities accompanying heart disease, such as diabetes, obesity and hypertension.
The Heart-Aorta Link
“Previous cardiac research focused on the heart while failing to account for the relationship between the heart and the aorta, despite their intimate connection,” said Dr. Rodriguez. “For example, aortic stiffness significantly increases with age and is associated with heart failure and hypertension, but how that occurs isn’t well understood. We hypothesize that aortic stiffness impairs the mechanical interaction, or ‘coupling,’ between the aorta and the heart, which in turn contributes to heart failure. We’re hoping this study will shed light on these mechanisms and that we can use the heart-aorta relationship to help identify people who are at risk for heart failure earlier.”
Researchers will recruit approximately 1,600 Hispanic/Latino men and women over 45 who previously enrolled in the Echocardiographic Study of Latinos (ECHO-SOL), part of the NIH-funded Hispanic Community Health Study/Study of Latinos (HCHS/SOL), which is an ongoing clinical study with more than 16,000 participants over 18 years of age at four U.S. sites, including Einstein. In the new study, participants will receive echocardiograms along with other tests focused on determining the stiffness and functioning of the aorta, aorta-left ventricle coupling abnormalities, and the possible presence of heart failure and pre-heart failure.
Once the research is complete, Dr. Rodriguez and colleagues will compare their findings to data on vascular function in non-Hispanic white and Black men and women from the Framingham Heart Study and the Jackson Heart Study, with the goal of recognizing similarities and disparities among racial and ethnic groups.
"We hope our study leads to new ways of identifying people at high risk of heart failure or for detecting it earlier, providing an opportunity to intervene to prevent severe disease,” said Dr. Rodriguez. “Our ultimate aim is to lower the burden of heart failure in this under-studied population."
The grant, titled “Vascular Determinants of Stage B HF among Hispanics: the role of the Heart-Vascular Interaction,” is funded by the National Heart, Lung, and Blood Institute, part of the NIH (1R01HL158156).
***
About Albert Einstein College of Medicine
is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2022-23 academic year, Einstein is home to 740 students, 194 students, 118 students in the , and approximately 225 . The College of Medicine has more than 1,900 full-time faculty members located on the main campus and at its . In 2022, Einstein received more than $202 million in awards from the National Institutes of Health. This includes the funding of major at Einstein in cancer, aging, intellectual development disorders, diabetes, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with , the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. For more information, please visit , follow us on , , , , and view us on .
About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 10 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information, please visit . Follow us on and and , or view us on and .